Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
6.44
-0.45 (-6.53%)
At close: Aug 20, 2026, 4:00 PM EDT
6.78
+0.34 (5.28%)
After-hours: Aug 20, 2026, 5:55 PM EDT
Aligos Therapeutics Market Cap
Aligos Therapeutics has a market cap or net worth of $40.21 million as of August 20, 2026. Its market cap has decreased by -25.88% in one year.
Market Cap
40.21M
Enterprise Value
13.34M
1-Year Change
-25.88%
Ranking
Category
Stock Price
$6.44
ChartMarket Cap Chart
Since the IPO on October 16, 2020, Aligos Therapeutics's market cap has decreased from $553.35M to $40.21M, a decrease of -92.73%. That is a compound annual growth rate of -36.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 40.21M | -29.88% |
| Dec 31, 2025 | 57.35M | -61.21% |
| Dec 31, 2024 | 147.87M | 197.20% |
| Dec 29, 2023 | 49.75M | 21.95% |
| Dec 30, 2022 | 40.80M | -91.93% |
| Dec 31, 2021 | 505.85M | -52.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Veraxa Biotech AG | 46.90M |
| Metagenomi Therapeutics | 46.09M |
| Grace Therapeutics | 45.44M |
| Veru Inc. | 44.84M |
| Seres Therapeutics | 44.84M |
| Hyperion DeFi | 43.05M |
| Filana Therapeutics | 42.99M |
| Serina Therapeutics | 42.74M |